Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $149.6500 (1.46%) ($149.6500 - $149.6500) on Wed. Mar. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.21% (three month average) | RSI | 50 | Latest Price | $149.6500(1.46%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -0.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(51%) XBI(43%) ARKG(36%) IWO(35%) ARKK(32%) | Factors Impacting SGEN price | SGEN will decline at least -1.605% in a week (0% probabilities). VIXM(-22%) VXX(-10%) UUP(-9%) TBT(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.605% (StdDev 3.21%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $151.71 | 5 Day Moving Average | $150.34(-0.46%) | 10 Day Moving Average | $149.57(0.05%) | 20 Day Moving Average | $151.71(-1.36%) | To recent high | -25.4% | To recent low | 3% | Market Cap | $26.019b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |